Sign in
CompletedNo phase

HEARTPrep: A Virtually-delivered Psychosocial Intervention for Mothers Expecting a Baby With Congenital Heart Disease

Key facts

Who runs it
Nemours Children's Clinic
Where
Wilmington, United StatesSee the site
Trial code
Status
Completed
People taking part
30 people enrolled
Started
14 Jul 2023
Ended
31 May 2025
Type of study
Interventional
Treatments tested
  • HEARTPrep
Record updated
31 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Expectant mothers carrying a fetus with congenital heart disease expected to require cardiac surgery in the first year of life
  • Partners of participating expectant mothers can also participate together with the mother
  • Receiving fetal cardiac care at Nemours Children's Health
  • Speaks English or Spanish fluently
  • Age 18 or older
  • Access to a computer, tablet or mobile device with internet access

Who cannot take part

  • -Fetus has a genetic syndrome or other comorbid condition associated with a life expectancy of less than one year

Where in United States

  • Nemours Children's HealthWilmington, United States

About the trial

What the trial wants to find out

Congenital heart disease (CHD) is the most common birth defect and is increasingly diagnosed prenatally. Mothers describe their prenatal experiences as highly stressful and traumatic after a diagnosis of CHD. Maternal stress during pregnancy exerts a powerful influence on birth outcomes and developmental trajectories, particularly for children in underserved populations. In partnership with diverse parent and clinician stakeholders, our team designed HEARTPrep, an innovative, virtually-delivered psychosocial intervention for mothers expecting a baby with CHD. This project will pilot HEARTPrep with mothers expecting a baby with CHD to obtain preliminary data for a larger future trial. This intervention has the potential to improve emotional wellbeing in mothers expecting a baby with CHD, thereby altering developmental trajectories for this large population of children.

The group in the trial

  • HEARTPrepTreatment being tested

    HEARTPrep is a virtually-delivered psychosocial intervention for mothers expecting a baby with CHD. HEARTPrep consists of three distinct modules: Adjusting, Connecting, and Preparing. Each module targets one distinct primary outcome (emotional distress, social isolation, parenting self-efficacy) and a common secondary outcome (hope) through a suite of evidence-based intervention elements (e.g., psychoeducation, cognitive restructuring, mindfulness) for addressing emotional problems in other populations, including pregnant women. HEARTPrep elements include: a) telehealth with a psychosocial provider, b) recorded videos, c) educational tools, and d) links to resources.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
31 August 2026